Nanotechnology

Regenerative Medicine

'Smart Bomb' Nanoparticle Strategy Impacts Metastasis

Posted in Biotechnology, Nanotechnology, Nanotechnology on Mon July 14, 2008

A new treatment strategy using molecular "smart bombs" to target metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the University of California, San Diego. ... Continue Reading

Accidental fungus leads to promising cancer drug

A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S. researchers reported on Sunday. ... Continue Reading

New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers

The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children’s Hospital Boston. ... Continue Reading

Nanotech to Regrow Cartilage and Soothe Aching Knees

Posted in Biotechnology, Nanotechnology, Nanotechnology on Mon June 23, 2008

Researchers use carbon nanotubes and electricity to coax the growth of stronger, bone-cushioning tissue ... Continue Reading

Rupturing The Nanotech Rapture

Posted in Biotechnology, Nanotechnology, Nanotechnology on Thu June 05, 2008

How to usher humanity into an era of transhumanist bliss: first, end scarcity. Second, eradicate death. Third, eliminate the bungled mechanisms that introduce imperfections into the human body. The vehicle for accomplishing all three? Molecular nanotechnology—in essence, the reduction of all material things to the status of software. ... Continue Reading

Gene therapy increases survival for end-stage head and neck cancer

A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. Introgen Therapeutics, Inc., reported results of its phase III trial of Advexin(r), a modified adenovirus that expresses the tumor-suppressing gene p53, for end-stage head and neck cancer. ... Continue Reading

Carbon Nanotubes May Pose Same Cancer Risk As Asbestos

Posted in Biotechnology, Nanotechnology, Nanotechnology on Wed May 21, 2008

Scientists have come out and stated that carbon nanotubes may prove to be just as harmful as asbestos in terms of putting people at risk of developing cancer. ... Continue Reading

Emerging Research Heralds New Era Of Breast Cancer Management

Posted in Women's Health, Nanotechnology on Thu March 01, 2007

Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review. The review reveals that new approaches in breast cancer imaging, investigations into the timing of chemotherapy and research on breast cancer vaccines may lead to exciting new nonsurgical tools for the physician treating breast cancer patients. ... Continue Reading

Minimally Invasive Cancer Treatments Highlighted

Posted in Cancer, Nanotechnology on Wed February 21, 2007

Clinicians and basic scientists from academia, private practice, government and industry are coming together for a week-long multi-disciplinary symposium in interventional oncology, a rapidly growing area of medicine involving minimally invasive interventional radiology treatments for cancer. The first two days of the meeting focus on treatments for liver, kidney, bone and lung tumors. ... Continue Reading

Researchers Probe Health And Safety Impacts Of Nanotechnology

Posted in Nanotechnology, Nanotechnology on Mon February 19, 2007

University of Florida engineering student Maria Palazuelos is working on nanotechnology, but she ... Continue Reading

Page: 1 2 3 4 5 6 7 8 9 10...  | 

Subscribe to the EBN

The Longevity Newsletter

We respect your privacy
getlisted Virtual Exhibit Hall feedback what-is-rss